Patent details

EP1504035 Title: ANTIBODIES SPECIFIC FOR HUMAN CD22 AND THEIR THERAPEUTIC AND DIAGNOSTIC USES

Basic Information

Publication number:
EP1504035
PCT Application Number:
GB2003001934
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP037189743
PCT Publication Number:
WO2003093320
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTIBODIES SPECIFIC FOR HUMAN CD22 AND THEIR THERAPEUTIC AND DIAGNOSTIC USES
French Title of Invention:
ANTICORPS SPECIFIQUES A L' HUMAIN CD22 ET LEURS UTILISATION THERAPEUTIQUES ET DIAGNOSTIQUES
German Title of Invention:
ANTIKÖRPER GEGEN HUMANES CD22 UND DEREN THERAPEUTISCHE UND DIAGNOSTISCHE VERWENDUNGEN
SPC Number:
LUC00057
LUC00058

Dates

Filing date:
02/05/2003
Grant date:
31/03/2010
EP Publication Date:
09/02/2005
PCT Publication Date:
13/11/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/02/2005
EP B1 Publication Date:
31/03/2010
EP B2 Publication Date:
EP B3 Publication Date:
20/12/2017
Lapsed date:
Expiration date:
02/05/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/12/2017
 
 

Name:
UCB Pharma, S.A.
Address:
Allée de La Recherche 60, 1070 Brussels, Belgium (BE)

Inventor

1

Name:
LADYMAN, Heather Margaret
Address:
United Kingdom (GB)

2

Name:
TICKLE, Simon Peter
Address:
United Kingdom (GB)

3

Name:
POPPLEWELL, Andrew George
Address:
United Kingdom (GB)

Priority

Priority Number:
0210121
Priority Date:
02/05/2002
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 31/7088; A61K 39/395; A61P 35/00; C07K 16/28; C12N 5/10; C12N 15/13; C12N 15/85;

Publication

European Patent Bulletin

1

Issue number:
201745
Publication date:
08/11/2017
Description:
Request for limitation Filed (Art.105a)

2

Issue number:
201749
Publication date:
06/12/2017
Description:
Request for limitation of patent allowed

3

Issue number:
201751
Publication date:
20/12/2017
Description:
Limited Patent Specification (B3)

4

Issue number:
201809
Publication date:
28/02/2018
Description:
Document reprinted after correction (B8, B9)

5

Issue number:
201842
Publication date:
17/10/2018
Description:
Document reprinted after correction (B8, B9)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
29/04/2022
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages